ChiCTR2600125074 版本V1.0 版本创建时间2026/05/21 09:29:52 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600125074 

最近更新日期:

Date of Last Refreshed on:

2026-05-21 09:29:34 

注册时间:

Date of Registration:

2026-05-21 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

对比不同入路髋关节置换术和内固定术治疗老年粗隆间骨折疗效的临床研究

Public title:

Clinical study comparing the efficacy of different approaches for hip replacement and internal fixation in the treatment of intertrochanteric fractures in elderly patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

对比不同入路髋关节置换术和内固定术治疗老年粗隆间骨折疗效的临床研究

Scientific title:

Clinical study comparing the efficacy of different approaches for hip replacement and internal fixation in the treatment of intertrochanteric fractures in elderly patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

贾延峰 

研究负责人:

贾延峰 

Applicant:

Yanfeng Jia 

Study leader:

Yanfeng Jia 

申请注册联系人电话:

Applicant telephone:

+86 84995266

研究负责人电话:

Study leader's telephone:

+86 176 3313 0622

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

ajiayanfeng1@yeah.net

研究负责人电子邮件:

Study leader's E-mail:

ajiayanfeng1@yeah.net

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

江苏省泰州市靖江市中洲东路28号

研究负责人通讯地址:

江苏省泰州市靖江市中洲东路28号

Applicant address:

No. 28, Zhongzhou East Road, Jingjiang City, Taizhou City, Jiangsu Province

Study leader's address:

No. 28, Zhongzhou East Road, Jingjiang City, Taizhou City, Jiangsu Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

靖江市人民医院

Applicant's institution:

Jingjiang People's Hospital

研究负责人所在单位:

靖江市人民医院

Affiliation of the Leader:

Jingjiang People's Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2026-KY-018-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

靖江市人民医院伦理委员会

Name of the ethic committee:

Ethics Committee of Jingjiang People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2026-03-31 00:00:00

伦理委员会联系人:

吕剑

Contact Name of the ethic committee:

Lv Jian

伦理委员会联系地址:

江苏省泰州市靖江市中洲东路28号

Contact Address of the ethic committee:

No. 28, Zhongzhou East Road, Jingjiang City, Taizhou City, Jiangsu Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 523 8499 5123

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

靖江市人民医院

Primary sponsor:

Jingjiang People's Hospital

研究实施负责(组长)单位地址:

江苏省泰州市靖江市中洲东路28号

Primary sponsor's address:

No. 28, Zhongzhou East Road, Jingjiang City, Taizhou City, Jiangsu Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏省

市(区县):

靖江市

Country:

China

Province:

Jiangsu

City:

Jingjiang

单位(医院):

靖江市人民医院

具体地址:

江苏省泰州市靖江市中洲东路28号

Institution
hospital:

Jingjiang People's Hospital

Address:

No. 28, Zhongzhou East Road, Jingjiang City, Taizhou City, Jiangsu Province

经费或物资来源:

靖江市人民医院院级课题

Source(s) of funding:

Jingjiang People's Hospital Hospital-Level Project

Target disease:

Femoral intertrochanteric fracture

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

回顾性研究 

Study phase:

Retrospective study

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

本研究旨在通过回顾性对比分析直接前入路(DAA)、后外侧入路(PLA)髋关节置换术与内固定术治疗高龄股骨粗隆间骨折的临床疗效并探讨最优术式适用人群  

Objectives of Study:

This study aims to retrospectively compare and analyze the clinical efficacy of direct anterior approach (DAA), posterior lateral approach (PLA) hip replacement surgery, and internal fixation in the treatment of intertrochanteric fractures in elderly patients, and to explore the optimal surgical approach for different patient populations.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 年龄≥70岁,男女不限 2. 闭合性股骨粗隆间骨折 3. 受伤时间≤7天 4. BMI<30。

Inclusion criteria

1. Aged >=70, male or female 2. Closed intertrochanteric fracture of femur 3. Injury duration <= 7 days 4. BMI < 30.

排除标准:

1. 病理性骨折或开放性骨折 2. 既往同侧髋关节手术史或严重髋关节疾病 3. 认知功能障碍无法配合康复及随访(MMSE<18分) 4. 随访数据记录不全或丢失。

Exclusion criteria:

1. Pathological fracture or open fracture 2. Previous ipsilateral hip surgery history or severe hip joint disease 3. Cognitive dysfunction, unable to cooperate with rehabilitation and follow-up (MMSE < 18 points) 4. Follow-up data is incomplete or missing.

研究实施时间:

Study execute time:

From 2026-04-01 00:00:00 To 2029-03-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-06-01 00:00:00 To 2026-12-01 00:00:00  

干预措施:

Interventions:

组别:

DAA关节置换组

样本量:

80

Group:

DAA arthroplasty group

Sample size:

干预措施:

干预措施代码:

Intervention:

No

Intervention code:

组别:

PLA关节置换组

样本量:

80

Group:

PLA arthroplasty group

Sample size:

干预措施:

干预措施代码:

Intervention:

No

Intervention code:

组别:

内固定组

样本量:

80

Group:

internal fixation group

Sample size:

干预措施:

干预措施代码:

Intervention:

No

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江苏省 

市(区县):

靖江市 

Country:

China 

Province:

Jiangsu 

City:

Jingjiang 

单位(医院):

靖江市人民医院 

单位级别:

三甲 

Institution
hospital:

Jingjiang People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

哈里斯髋关节评分

指标类型:

主要指标

Outcome:

Harris Hip Score

Type:

Primary indicator

测量时间点:

测量方法:

患者填写

Measure time point of outcome:

Measure method:

Patient fills out

指标中文名:

假体下沉

指标类型:

主要指标

Outcome:

prosthesis subsidence

Type:

Primary indicator

测量时间点:

测量方法:

X光片测量

Measure time point of outcome:

Measure method:

X-ray measurement

指标中文名:

首次下床时间

指标类型:

主要指标

Outcome:

First time out of bed

Type:

Primary indicator

测量时间点:

测量方法:

随访记录

Measure time point of outcome:

Measure method:

Follow-up record

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

No

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 70 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不共享

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Do not share

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

由课题组成员收集记录在病例记录表中,并将数据保持至科室电脑加密文件中。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The data will be collected and recorded by the members of the research team in the case record form, and will be kept in the encrypted file on the department's computer.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-05-21 09:29:34